Patent · US Active

Treatment of carpal tunnel syndrome by injection of the flexor retinaculum

US9108005B2 · kind B2 · utility

2Cited by
11References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 13, 2014
Grant dateAug 18, 2015
Priority date
Expiry dateJan 13, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2210/083
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An apparatus and method for identifying the flexor retinaculum of the carpal tunnel, injecting an effective amount of an agent into at least a portion of flexor retinaculum or tissue adjacent thereto, wherein the agent is configured to weaken the flexor retinaculum. The system may further include means for increasing the tensile stress in the flexor retinaculum post-injection using hand exercises, thereby weakening its structural integrity and decreasing the pressure within the carpal tunnel that impairs median nerve function.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.